Centenial Surgical Suture Ltd. (BSE: 531380) is a Thane, Maharashtra-based company in the Medical Consumables industry. With a market capitalisation of ₹25 Cr, it ranks #4,453 by market cap among the 6,189 Indian listed companies on FinBizNet, and #13 of 14 in Medical Consumables. At ₹67.95 (as of 26 Oct 2026), the share price is 45.6% below its 52-week high of ₹124.90 and 0.3% above its 52-week low of ₹67.75. The share price is down 36.4% over one year and down 15.6% over three months.
| Current Price | ₹67.95 |
|---|---|
| Market Cap | ₹25 Cr |
| BSE Code | 531380 |
| Sector | Health Care > Health Care Equipment and Services > Health Care Equipment and Supplies |
| Sub-Industry | Health Care Supplies > Medical Consumables |
| P/E Ratio | -11.2 |
| Return on Equity | -7.43% |
| Return on Assets | 0.83% |
| 52-Week Range | ₹67.75 – ₹124.90 |
| 1-Year Price Change | -36.4% |
| 3-Month Price Change | -15.6% |
| Beta (1Y) | 0.92 |
| Headquarters | Thane, Maharashtra |
| Website | centenialindia.com |
Centenial Surgical Suture Ltd., a medical device company, engages in the manufacture and sale of surgical sutures and other medical devices in India and internationally. It provides absorbable sutures, such as catgut, centicryl, centicryl rapid, centisorb, centisorb rapid, centisorb tri-plus, centisynth, and monosynth; non-absorbable sutures, including centibond, centidene, centilene, centisilk, centlon, and centsteel; and superior atraumatic needle products. The company also provides cardiovascular sutures, which include centibond, centiiwax, centilene, and centsteel; and other medical devices that comprise centipunch, centcel, centiitape, centiiwax, centilene mesh, centipace, and centipled, as well as disposable surgical skin stapler. Centenial Surgical Suture Ltd. was incorporated in 1995 and is based in Thane, India.
1. Medical Devices-This segment engages in the manufacture and sale of medical devices.
1. Medical Devices-100%
| Company | Market Cap | P/E | ROE | Latest Qtr Revenue | 1Y Change |
|---|---|---|---|---|---|
| Poly Medicure Ltd. | ₹14,628 Cr | 45.5 | 10.84% | ₹525 Cr | -24.8% |
| Sahajanand Medical Technologies | ₹3,715 Cr | 58.3 | — | — | — |
| Q-Line Biotech Limited | ₹1,235 Cr | 15 | — | — | — |
| Laxmi Dental Limited | ₹936 Cr | 32.4 | 12.77% | ₹75 Cr | -46.3% |
| Prevest Denpro Ltd | ₹453 Cr | 22.1 | 17.79% | — | -27.8% |
| Choksi Imaging Ltd. | ₹113 Cr | 21.2 | 13.51% | — | +131.2% |
| GSM Foils Limited | ₹81 Cr | 4.5 | — | ₹97 Cr | -70.6% |
| Mohini Health & Hygiene Ltd | ₹52 Cr | -3.1 | 5.69% | — | -44.8% |
| Centenial Surgical Suture Ltd. | ₹25 Cr | -11.2 | -7.43% | — | -36.4% |
Listed by market capitalisation. Ratios are shown for context only.
Centenial Surgical Suture Ltd. is trading at ₹67.95, with a market capitalisation of ₹25 Cr.
Centenial Surgical Suture Ltd. operates in the Health Care > Health Care Equipment and Services > Health Care Equipment and Supplies space (Health Care Supplies > Medical Consumables).
Centenial Surgical Suture Ltd. has a P/E of -11.2 and a return on equity of -7.43%.
Centenial Surgical Suture Ltd. is listed on the BSE under the scrip code 531380.
Centenial Surgical Suture Ltd.'s share price is down 36.4% over one year and down 15.6% over three months. Its 52-week range is ₹67.75 to ₹124.90.
Data as of 26 Oct 2026. Descriptive market data only — not investment advice.